Overview

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

Status:
NOT_YET_RECRUITING

Trial end date:
2029-10-29

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of bimekizumab compared with placebo in participants with palmoplantar pustulosis (PPP).

Phase:

PHASE3

Details

Lead Sponsor:

UCB Biopharma SRL

Treatments:

bimekizumab